Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of HSPB8 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane affects the expression of HSPB8 mRNA | affects expression | 18648102
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of HSPB8 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of HSPB8 mRNA | affects expression | 17562736
|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of HSPB8 mRNA | increases expression | 17202762
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of HSPB8 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of HSPB8 mRNA | affects expression | 16483693
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Ozone results in increased expression of HSPB8 mRNA] | increases expression|increases reaction | 17460151
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of HSPB8 mRNA | increases expression | 18687144
|
D016589 |
Astemizole |
Astemizole results in increased expression of HSPB8 mRNA | increases expression | 20221588
|
D019324 |
beta-Naphthoflavone |
beta-Naphthoflavone results in increased expression of HSPB8 mRNA | increases expression | 19737606
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of HSPB8 mRNA | increases expression | 20106945
|
C006780 |
bisphenol A |
bisphenol A inhibits the reaction [Triiodothyronine results in increased expression of HSPB8 mRNA] | decreases reaction|increases expression | 19228888
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of HSPB8 mRNA | increases expression | 14729362
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of HSPB8 mRNA | increases expression | 20106945
|
C044101 |
endotoxin, Escherichia coli |
endotoxin, Escherichia coli results in increased expression of HSPB8 mRNA | increases expression | 15919760
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HSPB8 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of HSPB8 mRNA | increases expression | 20106945 19619570
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of HSPB8 mRNA | increases expression | 16557594
|
D017313 |
Fenretinide |
Fenretinide results in increased expression of HSPB8 mRNA | increases expression | 16671099
|
C029424 |
hydrazine |
hydrazine results in increased expression of HSPB8 mRNA | increases expression | 15282401
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of HSPB8 mRNA | increases expression | 14729362
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of HSPB8 mRNA | increases expression | 15919760
|
C002950 |
methylformamide |
methylformamide affects the expression of HSPB8 mRNA | affects expression | 17040096
|
C002950 |
methylformamide |
methylformamide analog affects the expression of HSPB8 mRNA | affects expression | 17040096
|
D010126 |
Ozone |
anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Ozone results in increased expression of HSPB8 mRNA] | increases expression|increases reaction | 17460151
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of HSPB8 mRNA | increases expression | 18445702
|
C031280 |
pyrazole |
pyrazole results in increased expression of HSPB8 mRNA | increases expression | 17945193
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of HSPB8 mRNA | affects cotreatment|decreases expression | 19059307
|
C064116 |
S-(1,1,2,2-tetrafluoroethyl)cysteine |
S-(1,1,2,2-tetrafluoroethyl)cysteine results in increased expression of HSPB8 mRNA | increases expression | 16678137
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of HSPB8 mRNA | increases expression | 16014739
|
D014284 |
Triiodothyronine |
bisphenol A inhibits the reaction [Triiodothyronine results in increased expression of HSPB8 mRNA] | decreases reaction|increases expression | 19228888
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of HSPB8 mRNA | increases expression | 19228888
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of HSPB8 mRNA | affects cotreatment|decreases expression | 19059307
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of HSPB8 mRNA | decreases expression | 16443690
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HSPB8 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of HSPB8 mRNA | increases expression | 20106945 19619570
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.25 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
7.50 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.50 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.26 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.14 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.14 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.56 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.56 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
9.56 | 10697514 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
9.56 | 17638652 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
10.20 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
10.20 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
10.20 | 19389873 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.92 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.92 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.40 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.60 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.31 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.13 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
4.13 | 15800139 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.83 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.83 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
11.03 | 10982225 |
MESH:D000799 |
Angioedema |
|
Astemizole |
11.03 | 2883202 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.78 | 19183758 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.49 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.55 | 17854713 16373670 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.45 | 18445737 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.72 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.89 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.89 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.49 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.58 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.60 | 11985600 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.19 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.10 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.48 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
4.48 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.48 | 16675129 17289903 19861407 12948864 17261762 18497071 17018787 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
4.48 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
4.48 | 19217205 16557594 15136595 18357371 16110121 16595493 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
4.48 | 16912660 17595753 17893378 17952589 15758505 15775269 15572757 16837676 17440819 17261762 17242785 17049068 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.48 | 18425577 18629630 19410462 19142967 21138602 18351453 17242785 19221464 19200415 19011961 19066611 17893378 16873071 16202921 19059307 19155303 20859285 15668708 19289846 19189212 16818667 18815881 19487384 19084267 19288272 11161223 17049068 21152245 20005174 18855134 18997820 19189210 18821012 20135344 18984771 17261762 17440819 20544844 20390343 19115204 20065188 15565566 16273361 19244106 19103187 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.48 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.45 | 18315731 17626835 15516495 19059883 18417511 16777450 14754758 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.44 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.17 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.37 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.42 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.42 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.22 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
21.86 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
21.86 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
21.86 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
21.86 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
21.86 | 19418558 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
21.86 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
21.86 | 16270382 17159502 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
21.86 | 17971768 18930000 17045692 17088986 16332177 16799960 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
21.86 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
21.86 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.69 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.03 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
6.03 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.08 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
10.08 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
10.08 | 16757204 18986760 17066447 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.08 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.65 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.65 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.21 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
6.91 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
6.91 | 15775269 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
6.85 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.85 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
14.36 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
14.36 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
14.36 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
14.36 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
5.18 | 16154183 |
OMIM:608673 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L |
marker/mechanism |
|
| |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.92 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
12.13 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.13 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.13 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.98 | 16354765 15340226 15668235 8697196 12621046 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.33 | 15800139 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.19 | 15001691 16340194 16510598 18772588 17725105 17018589 17172411 17169374 17016597 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
2.77 | 17273769 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.77 | 17695437 15289873 18383874 16391804 18509181 14970324 20501625 18448328 17454858 16524972 16282729 18288408 18802399 18949393 17401013 17255274 15148649 17094418 16303861 17016601 16331619 17594712 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
8.37 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.37 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.24 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.73 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.50 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.07 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.92 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.53 | 14531868 8970840 11906362 11298694 18759878 2524372 12868966 8156756 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.29 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.22 | 2952479 3621924 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.60 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.60 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
13.60 | 17308373 17451421 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
13.60 | 19279558 |
MESH:D004244 |
Dizziness |
|
Astemizole |
6.17 | 3105558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
14.05 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
14.05 | 18692083 6482804 18289764 1440618 9022650 16192314 6679447 11289319 8291058 7440962 9653073 18648102 9328219 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
14.05 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
14.05 | 19164858 16109766 12594235 19739265 17562736 11421492 19370779 14725611 16485898 16177239 16393943 17906064 12153990 11461765 14550746 10663392 15619225 14986274 12540782 19085960 19923254 11287661 2444490 11834606 19420014 15968718 18713872 16227642 11739529 10915739 12392966 16081117 11743745 16781746 10774834 12705907 11529661 17522070 18071297 19416960 12958197 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
pyrazole |
14.05 | 12499123 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
14.05 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.80 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.55 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
9.92 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
9.92 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
9.92 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.60 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
8.31 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.31 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.75 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.75 | 17893378 19155303 16202921 20544844 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.77 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
endotoxin, Escherichia coli |
10.07 | 17637181 18509659 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
10.07 | 15821434 17637181 15328337 |
MESH:D004802 |
Eosinophilia |
|
Astemizole |
4.52 | 1355641 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.76 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.76 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
6.76 | 15173087 16481741 16337965 17638652 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.80 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
16.61 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
16.61 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
16.61 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
16.61 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.06 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.17 | 11858732 |
MESH:D005334 |
Fever |
|
endotoxin, Escherichia coli |
8.91 | 16997862 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
8.91 | 9205823 11852909 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.72 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.23 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.89 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
7.52 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.52 | 20067830 |
MESH:D005499 |
Folliculitis |
|
Astemizole |
5.62 | 1671328 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.38 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.38 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.92 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
3.70 | 16187019 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.75 | 16145905 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.76 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.29 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.19 | 15102660 15162350 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.93 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.93 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.33 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.36 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.13 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.13 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.07 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.23 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.30 | 19176532 19772884 18467677 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.30 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.73 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.91 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.45 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.75 | 8697196 18606429 15340226 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.47 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.93 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.65 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.90 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
7.90 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.90 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.80 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
7.43 | 9205823 12878042 17963957 17237260 17255318 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.43 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.43 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
11.21 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
11.21 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
11.21 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.36 | 17255318 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.72 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.14 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
13.01 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
13.01 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
13.01 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
13.01 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.01 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
26.01 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
26.01 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
26.01 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
26.01 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
26.01 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
26.01 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.22 | 16973256 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
5.08 | 16972261 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.40 | 15821434 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.74 | 16707609 |
MESH:D017513 |
Lichen Nitidus |
|
Astemizole |
6.17 | 2563723 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.95 | 15342952 17567588 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.01 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.30 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
6.30 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.30 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.30 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.30 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.56 | 19460945 16611625 12969438 11587558 19014921 12587719 19784758 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.98 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
23.93 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
23.93 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
23.93 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
23.93 | 17045692 16603448 15113037 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
23.93 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
23.93 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
23.93 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
23.93 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
12.62 | 598648 1399818 3712494 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
12.62 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
12.62 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.62 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Astemizole |
4.37 | 18472280 11989578 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
6.86 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.86 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
13.58 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
13.58 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Ozone |
13.58 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
10.08 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
10.08 | 18569708 20135361 20464547 20064080 18816296 20869020 18520028 17053015 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
10.08 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
10.08 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
10.08 | 19931552 15276417 16712894 17077188 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
10.08 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.08 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.50 | 15086387 |
MESH:D008288 |
Malaria |
|
Astemizole |
4.54 | 16816845 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.47 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
8.97 | 16891317 11807958 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
8.97 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
8.97 | 11731420 19196723 14580682 19196722 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.65 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.65 | 19453300 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
4.88 | 16270382 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.88 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.88 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.89 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.28 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.07 | 16966607 18303189 16166281 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.49 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.81 | 10496685 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.25 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
13.17 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
13.17 | 16274795 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
13.17 | 18986760 16757204 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.23 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.22 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.02 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.79 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.51 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.51 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.25 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.56 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.29 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.29 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.42 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
14.16 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
14.16 | 17353921 15958647 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
14.16 | 18600527 16928823 18239605 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
14.16 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
14.16 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.38 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.70 | 19200415 19189210 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.44 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.14 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.04 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
14.73 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.73 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.73 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
6.62 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.62 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.63 | 18514411 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.38 | 16303764 |
OMIM:158590 |
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA |
marker/mechanism |
|
| |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.24 | 16436463 |
MESH:D009759 |
Nystagmus, Pathologic |
|
Astemizole |
6.17 | 6135121 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.74 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
13.68 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
13.68 | 6482804 4026338 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
13.68 | 14694615 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.72 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.21 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
3.96 | 17823083 17893378 15579764 15758505 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.69 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.42 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
7.42 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.42 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.16 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
5.30 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.30 | 16500647 16929163 19003803 15113037 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
8.36 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
8.36 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.95 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.84 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.17 | 6228378 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.60 | 10923243 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
10.12 | 12224865 11605937 |
MESH:D011014 |
Pneumonia |
|
Ozone |
10.12 | 18007984 18929643 18381685 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.28 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.98 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
8.52 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.52 | 11399792 11896295 11118676 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.67 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.67 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.38 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.38 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.38 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.38 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.38 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.38 | 16536755 16220300 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.38 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.38 | 15067354 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.12 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.49 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.92 | 15814490 17365031 17975199 17322281 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.25 | 15770314 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.76 | 18722050 15538739 16160472 18286688 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.24 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.54 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.56 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
8.39 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
8.39 | 16303925 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Astemizole |
5.13 | 10822083 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.34 | 18551238 |
MESH:D012772 |
Shock, Septic |
|
endotoxin, Escherichia coli |
5.34 | 18063050 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
20.65 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
20.65 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
20.65 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
20.65 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
20.65 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
20.65 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.99 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.74 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.57 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.34 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.34 | 17522103 19015929 18396642 17498489 16424979 19084572 15786421 17172411 16951190 18567086 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.59 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.69 | 16045194 16684133 |
MESH:D013733 |
Testicular Diseases |
|
pyrazole |
4.52 | 6499806 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.91 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.60 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.67 | 6587162 6582329 3712494 7505956 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.71 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.71 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.73 | 16280240 |
MESH:D016171 |
Torsades de Pointes |
|
Astemizole |
4.91 | 9583453 8256756 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
22.31 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
22.31 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
22.31 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
22.31 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
22.31 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
22.31 | 11723127 17306315 16452187 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
22.31 | 8653321 16712894 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.02 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
8.13 | 10982225 |
MESH:D014581 |
Urticaria |
|
Astemizole |
8.13 | 2568189 2565098 2885854 1976298 3097109 3080510 2147912 2859714 2568013 3134034 1683191 2883202 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
14.50 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
14.50 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.50 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.71 | 14652134 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.68 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.13 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.29 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.91 | 16837676 |
MESH:D014717 |
Vertigo |
|
Astemizole |
6.17 | 3105558 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.25 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.95 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.14 | 17120751 |